Two kinds of bone morphogenetic protein (BMP) containing polymeric reservoirs made from poly(1actide-coglycolide) (PLG) and a mixture of PLGipoly(ethy1ene glycol) (PEG) (PLGPEG) were implanted into mice femoral muscles. In the PLGiPEG reservoir with BMP, bone formation was induced within 3 weeks. On
Bone morphogenetic protein encapsulated with a biodegradable and biocompatible polymer
β Scribed by Isobe, Masatsugu ;Amagasa, Teruo ;Oida, Shin-ichiro ;Yamazaki, Yasuharu ;Ishihara, Kazuhiko ;Nakabayashi, Nobuo
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 640 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0021-9304
No coin nor oath required. For personal study only.
β¦ Synopsis
To develop a controlled release system for bone morphogenetic protein (BMP), poly(DL-lactide-co-glycolide) (PLGA) capsules containing BMP were prepared by an interfacial precipitation method using a water-in-oil-in-water emulsion. The surface morphology, particle size distribution, and hydrolytic degradation rate of the PLGA capsules were examined. The encapsulation yield and release rate of BMP in vitro were measured using fluorescein isothiocyanate-labeled BMP. The amount of BMP released from PLGA capsules in-creased between days 3 and 5. In addition, the effectiveness of BMP encapsulated in PLGA to induce bone formation in vivo was also examined by subcutaneous implantation in rats. Complete digestion of the capsules and new bone formation including bone marrow were identified by histologic examination of harvested tissues at 3 weeks after implantation. These results demonstrated that encapsulation of BMP with PLGA could be a promising method to induce bone in clinics.
π SIMILAR VOLUMES
## Abstract To produce an osteogenic and bacteriocidal biomaterial for the treatment of infected nonunions or bone defects, a synthetic degradable block copolymer of polyβD,Lβlactic acid segments with randomly inserted __p__βdioxanone and polyethylene glycol (PLAβDXβPEG) segments was mixed with rec
## Abstract We have used Raman analysis to assess bone healing on different models. Benefits on the isolated or combined use of mineral trioxide aggregate, bone morphogenetic proteins, guided bone regeneration and laser on bone repair have been reported, but not their combination. We studied peaks
To determine if recombinant human bone morphogenetic protein-2 (rhBMP-2) can be adsorbed onto porous ceramic hydroxyapatite (HA) and promote the integration of HA to host bone, 54 subperiosteal pockets were created on the skulls of 19 adult Pasteurella-free white rabbits. Fourteen HA implants were s
Porous 50:50 poly(d,l lactide-co-glycolide) microspheres containing varying amounts of ''free'' recombinant human bone morphogenetic protein-2 (rhBMP-2) were evaluated for their ability to induce/enhance expression of osteoblastic characteristics by pluripotent mesenchymal cells in vitro. ''Free'' p
This study was carried out to determine the effect of recombinant human bone morphogenetic protein (rhBMP) pharmacokinetics (PK) on rhBMP-induced osteoinductive activity. It was our working hypothesis that the PK of a rhBMP significantly affects its osteoinductive activity. The PK of various rhBMPs